Abstract: Methods, apparatus, and business processes enabling individual chemists to design, order, and obtain data for multiple experiments or measurements in a timely and cost-effective manner. In particular implementations, the invention includes methods and apparatus for designing sets of custom experiments, ordering the execution of the experiments, communicating the order to a remote laboratory, executing the experiments at that laboratory using high-throughput technologies, and communicating the experimental results to the user.

Abstract: Methods, apparatus, and business processes enabling individual chemists to design, order, and obtain data for multiple experiments or measurements in a timely and cost-effective manner. In particular implementations, the invention includes methods and apparatus for designing sets of custom experiments, ordering the execution of the experiments, communicating the order to a remote laboratory, executing the experiments at that laboratory using high-throughput technologies, and communicating the experimental results to the user.

Abstract: This invention relates to dichelants, in particular compounds having two macrocyclic chelant groups linked by a bridge containing an ester or amide bond, especially compounds of formula Vb ##STR1## (wherein each X which may be the same or different is NZ, O or S, at least two Xs being NZ;each Z is a group R.sup.1 or a group CR.sup.1.sub.2 Y, at least one Z, and preferably 2 or 3 Zs, on each macrocyclic ring being a group CR.sup.1.sub.2 Y;each Y is a group CO.sub.2 H, PO.sub.3 H, SO.sub.3 H, CONR.sup.1.sub.2, CON(OR.sup.1)R.sup.1, CNS or CONR.sup.1 NR.sup.1.sub.2, preferably COOH;m is 0 or 1 or 2, preferably 1; each n is 2 or 3, preferably 2; q is 1 or 2, preferably 1;each R.sup.

Abstract: Compounds including tight molecular meshes, preferably curved in one or two directions, such as fullerenes and met-cars, can be used as carriers for diagnostic or therapeutic agents, especially diagnostic contrast agents.

Abstract: This invention relates to dichelants, in particular compounds having two macrocyclic chelant groups linked by a bridge containing an ester or amide bond, especially compounds of formula Vb ##STR1## (wherein each X which may be the same or different is NZ, O or S, at least two Xs being NZ;each Z is a group R.sup.1 or a group CR.sup.1.sub.2 Y, at least one Z, and preferably 2 or 3 Zs, on each macrocyclic ring being a group CR.sup.1.sub.2 Y;each Y is a group CO.sub.2 H, PO.sub.3 H, SO.sub.3 H, CONR.sup.1.sub.2, CON(OR.sup.1)R.sup.1, CNS or CONR.sup.1 NR.sup.1.sub.2, preferably COOH;m is 0 or 1 or 2, preferably 1; each n is 2 or 3, preferably 2; q is 1 or 2, preferably 1;each R.sup.

Abstract: There are provided vanadium compositions for use in the treatment of hypertension, obesity and diabetes, in particular improved oral compositions comprising oxovanadium (IV) chelates of monoprotic, bidentate oxygen, oxygen and oxygen, nitrogen coordinating ligands especially kojic acid and maltol.

Abstract: The invention relates to a process for the separation cf various dialkyl multinuclear aromatic compounds from a feed stream of mixed isomers of those compounds. A shape selective adsorbent is employed resulting in a process that is more efficient than processes based upon prior separation techniques. Of special interest are combination processes involving synthesis steps followed by sorption steps using the same shape selective materials.

Abstract: A process for the manufacture of resorcinol is described which relies upon the intermediacy of a .alpha.,.beta.-unsaturated ketone which can be reacted with a hydroxy moiety-containing compound to obtain a resorcinol precursor which is subsequently converted to resorcinol. In a specific embodiment, 2-cyclohexenone is reacted with water to obtain 3-hydroxycyclohexanone which is dehydrogenated to resorcinol. In another embodiment, 2-cyclohexenone is oxidized to cyclohexane-1,3-dione which is dehydragenated obtain resorcinol.

Abstract: The selective isopropylation of a naphthyl compound to diisopropylnaphthalene enhanced in the 2,6-diisopropylnaphthalene isomer is obtained in the presence of an acidic crystalline molecular sieve catalyst having twelve membered oxygen rings. The catalyst pore aperture dimension range from 5.5 .ANG. to 7.0 .ANG.. The user of these shape selective catalysts results in a diisopropylnephthalene stream which is enhanced in .beta. isomers and enhanced in the desired 2,6-diisopropylnaphthalene isomer. A particularly preferred catalyst is synthetic Mordenite having a specific Si/Al ratio and NMR characteristics. Specific catalyst modifications are also described to improve selectivity to the desired 2,6-diisopropylnaphthalene isomer.

Abstract: A process for the selective manufacture of 2,6-diisopropylnaphthalene from naphthalene advantageously combines an equilibration reactor to enhance the amount of monoisopropylnaphthalene fed to the alkylation reactor, and the use of a shape selective catalyst in the alkylation reactor, to obtain an alkylation reaction product in which the 2,6-diisopropylnaphthalene isomer comprises greater than 39 mole percent of the total diisopropylnaphthalene obtained. Further, this combination of reaction steps and conditions produces a reaction product in which the ratio of 2,6-diisopropylnaphthalene to 2,7-diisopropylnaphthalene is greater than 1.0, preferably greater than 1.2. Recycled process components are fed to the equilibration reactor where they are combined with fresh naphthalene feed to provide a monoisopropylnaphthalene enriched feed to the alkylation reactor.

Abstract: A process for the manufacture of resorcinol is described which relies upon the intermediacy of a .alpha.,.beta.-unsaturated ketone which can be reacted with a hydroxy moiety-containing compound to obtain a resorcinol precursor which is subsequently converted to resorcinol. In a specific embodiment, 2-cyclohexenone is reacted dehydrogenated to resorcinol. In antoher embodiment, 2-cyclohexenone is oxidized to cyclohexane-1,3-dione which is dehydragenated obtain resorcinol.

Abstract: The additional of redox-active metal components and ligands, alternatively or simultaneously, results in increased conversion and selectivity in the palladium-catalyzed oxidation of olefins to carbonyl products in the presence of polyoxoanions. In preferred modes, heteropolyoxoanions and Isopolyoxoanions containing tungsten, molybdenum and vanadium, individually or in combination, are described. The use of copper as the redox-active metal component shows reduced allylic reactivity. The elimination of chloride from the catalyst system provides substantial engineering advantages over the prior art, particularly, the reduction of corrosion and chloro-organic by-product formation. The use of redox-active metal components and/or ligands makes the palladium-polyoxoanion catalyst system industrially practicable.

Abstract: Amorphous, porous metallo phosphates wherein the metal is Al, Ti, Ba, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mg, Sc, Cu, Fe and La or mixtures thereof, having average pore diameter from about 5 Angstroms to about 50 Angstroms that are useful as catalysts and catalyst supports.

Abstract: Novel compositions of matter comprising Group VIII metal chelates of linear ferrocenyl phosphines, arsines or stibines. The complexes are useful recoverable hydroformylation catalysts.

Abstract: The addition of redox-active metal components and ligands, alternatively or simultaneously, results in increased conversion and selectivity in the palladium-catalyzed oxidation of olefins to carbonyl products in the presence of polyoxoanions. In preferred modes, heteropolyoxoanions and isopolyoxoanions containing tungsten, molybdenum and vanadium, individually or in combination, are described. The use of copper as the redox-active metal component shows reduced allylic reactivity. The elimination of chloride from the catalyst system provides substantial engineering advantages over the prior art, particularly, the reduction of corrosion and chloro-organic by-product formation. The use of redox-active metal components and/or ligands makes the palladium-polyoxoanion catalyst system industrially practicable.

Abstract: The addition of redox-active metal components and ligands, alternatively or simultaneously, results in increased conversion and selectivity in the palladium-catalyzed oxidation of olefins to carbonyl products in the presence of polyoxoanions. In preferred modes, heteropolyoxoanions and isopolyoxoanions containing tungsten, molybdenum and vanadium, individually or in combination, are described. The use of copper as the redox-active metal component shows reduced allylic reactivity. The elimination of chloride from the catalyst system provides substantial engineering advantages over the prior art, particularly, the reduction of corrosion and chloro-organic by-product formation. The use of redox-active metal components and/or ligands makes the palladium-polyoxoanion catalyst system industrially practicable.

Abstract: Novel linear polymers of ferrocene are prepared by the reaction of 1,1'-dilithioferrocene with controlled amounts of a dihaloorganylphosphine, arsine or stibine. The polymers form stable complexes with Group VIII metals which are useful as recoverable hydroformylation catalysts.

Abstract: High purity berlinite is prepared by formation of an organoaluminum phosphate hydrogel in an organic solvent and subsequently hydrolyzing the hydrogel by reaction with water at pH less than or equal to 3.0. The berlinite is useful as a replacement for silicon-based quartz in electronic applications and in piezoelectric devices.